Diagnosing and treating the failing right heart

Current Opinion in Cardiology

Volumn 30, Issue 3, 2015, Pages 292-300

  Ryan, John J ^a   Tedford, Ryan J ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

glycolysis; Randle's cycle; right heart failure; right ventricle; ventricular vascular coupling; Warburg effect

Indexed keywords

INOTROPIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; GLUTAMINE;

ASSISTED CIRCULATION; CLINICAL ASSESSMENT; CLINICAL TRIAL (TOPIC); CORONARY ARTERY BLOOD FLOW; ECHOCARDIOGRAPHY; FATTY ACID OXIDATION; GLYCOLYSIS; HEART AFTERLOAD; HEART CATHETERIZATION; HEART INDEX; HEART MUSCLE CONTRACTILITY; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE VOLUME; HEART VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; ECHOGRAPHY; HEART FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE; METABOLISM; PATHOPHYSIOLOGY; PULMONARY ARTERY;

ADRENERGIC BETA-ANTAGONISTS; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY; GLUCOSE; GLUTAMINE; GLYCOLYSIS; HEART FAILURE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; PULMONARY ARTERY; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84928554391     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000164     Document Type: Review

References (78)

1. van de Veerdonk MC, Kind T, Marcus JT, et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011; 58:2511-2519.
2. Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006; 174:1034-1041.
3. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001; 37:183-188.
4. Guazzi M, Bandera F, Pelissero G, et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: An index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol 2013; 305:H1373-H1381.
5. Melenovsky V, Hwang S, Lin G, et al. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014; 35:3452-3462.
6. Mohammed SF, Hussain I, Abou Ezzeddine OF, et al. Right ventricular function in heart failure with preserved ejection fraction: A community based study. Circulation 2014; 130:2310-2320.
7. Kirklin JK, Naftel DC, Pagani FD, et al. Sixth INTERMACS annual report: A 10,000-patient database. J Heart Lung Transplant 2014; 33:555-564.
8. Mehra MR, Park MH, Landzberg MJ, et al. Right heart failure: toward a common language. Pulm Circ 2013; 3:963-967.
9. Buckberg GD; the RESTORE Group. The ventricular septum: The lion of right ventricular function, and its impact on right ventricular restoration. Eur J Cardiothorac Surg 2006; 29:S272-S278.
10. Damiano RJ, La Follette P, Cox JL, et al. Significant left ventricular contribution to right ventricular systolic function. Am J Physiol Heart Circ Physiol 1991; 261:H1514-H1524.
11. Brown SB, Raina A, Katz D, et al. Longitudinal shortening accounts for the majority of right ventricular contraction and improves after pulmonary vasodilator therapy in normal subjects and patients with pulmonary arterial hypertension. Chest 2011; 140:27-33.
12. Abel FL, Waldhausen JA. Effects of alterations in pulmonary vascular resistance on right ventricular function. J Thorac Cardiovasc Surg 1967; 54:886-894.
13. Tedford RJ, Hassoun PM, Mathai SC, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading/clinical perspective. Circulation 2012; 125:289-297.
14. Gomez-Arroyo J, Santos-Martinez L, Aranda A, et al. Differences in right ventricular remodeling secondary to pressure overload in patients with pulmonary hypertension. Am J Respir Crit Care Med 2014; 189:603-606.
15. Paulin R, Michelakis ED. The metabolic theory of pulmonary arterial hypertension. Circ Res 2014; 115:148-164.
16. Oikawa M, Kagaya Y, Otani H, et al. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 2005; 45:1849-1855.
17. Archer SL, Fang YH, Ryan JJ, Piao L. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension. Pulm Circ 2013; 3:144-152.
18. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927; 8:519-530.
19. Bogaard HJ, Natarajan R, Henderson SC, et al. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009; 120:1951-1960.
20. Sutendra G, Dromparis P, Paulin R, et al. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension. J Mol Med 2013; 91:1315-1327.
21. Piao L, Fang YH, Parikh K, et al. Cardiac glutaminolysis: A maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension. J Mol Med 2013; 91:1185-1197.
22. Dang CV. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle 2010; 9:3884-3886.
23. Ryan JJ, Marsboom G, Fang YH, et al. PGC1alpha-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. Am J Respir Crit Care Med 2013; 187:865-878.
24. Gomez-Arroyo J, Mizuno S, Szczepanek K, et al. Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension. Circ Heart Fail 2013; 6:136-144.
25. Rich S, Pogoriler J, Husain AN, et al. Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension. Chest 2010; 138:1234-1239.
26. Mathai SC, Sibley CT, Forfia PR, et al. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension. J Rheumatol 2011; 38:2410-2418.
27. Mauritz G, Kind T, Marcus JT, et al. Progressive changes in right ventricular geometric shortening and long-term survival in pulmonary arterial hypertension. Chest 2012; 141:935-943.
28. Mercer-Rosa L, Parnell A, Forfia PR, et al. Tricuspid annular plane systolic excursion in the assessment of right ventricular function in children and adolescents after repair of tetralogy of Fallot. J Am Soc Echocardiogr 2013; 26:1322-1329.
29. Raina A, Vaidya A, Gertz ZM, et al. Marked changes in right ventricular contractile pattern after cardiothoracic surgery: implications for postsurgical assessment of right ventricular function. J Heart Lung Transplant 2013; 32:777-783.
30. Lehmann KG, Lee FA, McKenzie WB, et al. Onset of altered interventricular septal motion during cardiac surgery. Assessment by continuous intraoperative transesophageal echocardiography. Circulation 1990; 82:1325-1334.
31. Unsworth B, Casula RP, Kyriacou AA, et al. The right ventricular annular velocity reduction caused by coronary artery bypass graft surgery occurs at the moment of pericardial incision. Am Heart J 2009; 159:314-322.
32. Tamborini G, Muratori M, Brusoni D, et al. Is right ventricular systolic function reduced after cardiac surgery? A two-and three-dimensional echocardiographic study. Eur J Echocardiogr 2009; 10:630-634.
33. Shiran H, Zamanian RT, McConnell MV, et al. Relationship between echocardiographic and magnetic resonance derived measures of right ventricular size and function in patients with pulmonary hypertension. J Am Soc Echocardiogr 2014; 27:405-412.
34. Sachdev A, Villarraga HR, Frantz RP, et al. Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest 2011; 139:1299-1309.
35. Drakos SG, Janicki L, Horne BD, et al. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010; 105:1030-1035.
36. Grant AD, Smedira NG, Starling RC, Marwick TH. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol 2012; 60:521-528.
37. Cameli M, Righini FM, Lisi M, et al. Comparison of right versus left ventricular strain analysis as a predictor of outcome in patients with systolic heart failure referred for heart transplantation. Am J Cardiol 2013; 112:1778-1784.
38. Fine NM, Chen L, Bastiansen PM, et al. Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension. Circ Cardiovasc Imaging 2013; 6:711-721.
39. Hardegree EL, Sachdev A, Villarraga HR, et al. Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol 2013; 111:143-148.
40. Marston N, Brown JP, Olson N, et al. Right ventricular strain before and after pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Echocardiography 2014. [Epub ahead of print
41. Freed BH, Tsang W, Bhave NM, et al. Right ventricular strain in pulmonary arterial hypertension: A 2D echocardiography and cardiac magnetic resonance study. Echocardiography 2015; 32:257-263.
42. Vonk-Noordegraaf A, Haddad F, Chin KM, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 2013; 62:D22-D33.
43. van de Veerdonk MC, Marcus JT, Westerhof N, et al. Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension. Chest 2014. [Epub ahead of print
44. Peacock AJ, Crawley S, McLure L, et al. Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: The EURO-MR study. Circ Cardiovasc Imaging 2014; 7:107-114.
45. Meyer P, Filippatos GS, Ahmed MI, et al. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation 2010; 121:252-258.
46. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Ann Intern Med 1991; 115:343-349.
47. Benza RL, Miller DP, Gomberg-Maitland M, et al. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 2010; 122:164-172.
48. Tyberg JV, Taichman GC, Smith ER, et al. The relationship between pericardial pressure and right atrial pressure: An intraoperative study. Circulation 1986; 73:428-432.
49. Miller WL, Grill DE, Borlaug BA. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC Heart Fail 2013; 1:290-299.
50. Tampakakis E, Leary PJ, Selby VN, et al. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail 2015; 3:9-16.
51. Mahapatra S, Nishimura RA, Sorajja P, et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol 2006; 47:799-803.
52. Dupont M, Mullens W, Skouri HN, et al. Prognostic role of pulmonary arterial capacitance in advanced heart failure. Circ Heart Fail 2012; 5:778-785.
53. Pellegrini P, Rossi A, Pasotti M, et al. Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest 2014; 145:1064-1070.
54. Dragu R, Rispler S, Habib M, et al. Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension. Eur J Heart Fail 2015; 17:74-80.
55. Maughan WL, Shoukas AA, Sagawa K, Weisfeldt ML. Instantaneous pressure-volume relationship of the canine right ventricle. Circ Res 1979; 44:309-315.
56. Bishop A, White P, Oldershaw P, et al. Clinical application of the conductance catheter technique in the adult human right ventricle. Int J Cardiol 1997; 58:211-221.
57. Tedford RJ, Mudd JO, Girgis RE, et al. Right ventricular dysfunction in systemic sclerosis associated pulmonary arterial hypertension. Circ Heart Fail 2013; 6:953-963.
58. Brimioulle S, Wauthy P, Ewalenko P, et al. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 2003; 284:H1625-H1630.
59. Lambermont B, Segers P, Ghuysen A, et al. Comparison between single-beat and multiple-beat methods for estimation of right ventricular contractility. Crit Care Med 2004; 32:1886-1890.
60. Vanderpool RR, Pinsky MR, Naeije R, et al. RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart 2015; 101:37-43.
61. Sanz J, Garcá-Alvarez A, Ferná ndez-Friera L, et al. Right ventriculo-arterial coupling in pulmonary hypertension: A magnetic resonance study. Heart 2012; 98:238-243.
62. Trip P, Kind T, van de Veerdonk MC, et al. Accurate assessment of loadindependent right ventricular systolic function in patients with pulmonary hypertension. J Heart Lung Transplant 2013; 32:50-55.
63. Sunagawa K,MaughanWL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol Heart Circ Physiol 1983; 245:H773-H780.
64. Dandel M, Potapov E, Krabatsch T, et al. Load dependency of right ventricular performance is a major factor to be considered in decision making before ventricular assist device implantation. Circulation 2013; 128:S14-S23.
65. Guihaire J, Haddad F, Noly PE, et al. Right ventricular reserve in a piglet model of chronic pulmonary hypertension. Eur Respir J 2014. [Epub ahead of print
66. Sharma T, Lau EM, Choudhary P, et al. Dobutamine stress for evaluation of right ventricular reserve in pulmonary arterial hypertension. Eur Respir J 2014. [Epub ahead of print
67. Grü nig E, Tiede H, Enyimayew EO, et al. Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension. Circulation 2013; 128:2005-2015.
68. Blumberg FC, Arzt M, Lange T, et al. Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension. Eur J Heart Fail 2013; 15:771-775.
69. Ryan JJ, Butrous G, Maron BA. The heterogeneity of clinical practice patterns among an international cohort of pulmonary arterial hypertension experts. Pulm Circ 2014; 4:441-451.
70. Piao L, Fang YH, Parikh KS, et al. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: Therapeutic implications in pulmonary hypertension. Circulation 2012; 126:2859-2869.
71. Campo A, Mathai SC, Le Pavec J, et al. Outcomes of hospitalization for right heart failure in pulmonary arterial hypertension. Eur Respir J 2011; 38:359-367.
72. Kar B, Basra SS, Shah NR, Loyalka P. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation 2012; 125:1809-1817.
73. Bogaard HJ, Natarajan R, Mizuno S, et al. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med 2010; 182:652-660.
74. de Man FS, Handoko ML, van Ballegoij JJ, et al. Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail 2012; 5:97-105.
75. Drake JI, Gomez-Arroyo J, Dumur CI, et al. Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension. Physiol Genomics 2013; 45:449-461.
76. Grinnan D, Bogaard HJ, Grizzard J, et al. Treatment of group I pulmonary arterial hypertension with carvedilol is safe. Am J Respir Crit Care Med 2014; 189:1562-1564.
77. Thenappan T, Roy SS, Duval S, et al. b-Blocker therapy is not associated with adverse outcomes in patients with pulmonary arterial hypertension: A propensity score analysis. Circ Heart Fail 2014; 7:903-910.
78. Perros F, Ranchoux B, Izikki M, et al. Nebivolol for Improving Endothelial Dysfunction, Pulmonary Vascular Remodeling, and Right Heart Function in Pulmonary Hypertension. J Am Coll Cardiol 2015; 65:668-680.